Screener
Ardelyx ARDX Accrued medical affairs expenses
Accrued medical affairs expenses at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept ardx:AccruedMedicalAffairsExpensesCurrent.
The source filing: Ardelyx’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 4:05 PM EST
- Fiscal year
- FY2025
- Accession
- 0001437402-26-000013
| (in thousands) | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Accrued gross to net revenue liabilities | $30,272 | $10,112 |
| Accrued sales and marketing expenses | 4,598 | 3,696 |
| Accrued contract manufacturing expenses | 2,821 | 1,402 |
| Accrued medical affairs expenses | 2,538 | 817 |
| Accrued payments due to AstraZeneca | — | 12,077 |
| Other | 7,348 | 6,538 |
| Total accrued expenses and other current liabilities | $47,577 | $34,642 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Ardelyx's accrued medical affairs expenses?
- Ardelyx (ARDX) reported accrued medical affairs expenses of $2.54M in Q4 2025.
- What does accrued medical affairs expenses mean?
- Accrued medical affairs expenses as reported by Ardelyx, Inc..
Ask your AI about Ardelyx's accrued medical affairs expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude